| 2001 |
Nup160 and Nup133 are novel vertebrate nucleoporins that exist as a complex (Nup160 complex) together with Nup107, Nup96, and Sec13 in Xenopus egg extracts and in assembled nuclear pores. Nup98 and Nup153 each bind this complex, and specific fragments of Nup160 and Nup133 block poly[A]+ RNA (mRNA) export but not protein import or export, establishing a direct role in mRNA export. |
Pulldown from Xenopus egg extracts, co-immunoprecipitation, immunofluorescence, protein purification and sequencing, transfection with in vivo transport assays |
The Journal of cell biology |
High |
11684705
|
| 2001 |
The binding site on Nup98 for the Nup160 subcomplex is used to tether Nup98 to the nucleus; the binding site on Nup153 for the Nup160 subcomplex targets Nup153 to the nuclear pore. |
Domain mapping via pulldown experiments with fragments of Nup98 and Nup153 from Xenopus egg extracts, immunofluorescence |
The Journal of cell biology |
Medium |
11684705
|
| 2018 |
Knockdown of NUP160 in mouse podocytes inhibits cell proliferation by decreasing cyclin D1 and CDK4 expression, increasing p27, and inducing S-phase arrest; it also promotes apoptosis and autophagy, enhances cell migration, decreases expression of nephrin, podocin, and CD2AP, increases α-actinin-4, and alters subcellular localization of nephrin, podocin, and CD2AP. |
shRNA-mediated knockdown in conditionally immortalized mouse podocytes; Western blot, flow cytometry, immunofluorescence |
Gene |
Medium |
29704630
|
| 2019 |
Silencing of Drosophila NUP160 specifically in nephrocytes leads to functional abnormalities, reduced cell size and nuclear volume, and disorganized nuclear membrane structure; these defects are completely rescued by wild-type human NUP160, but not by the NUP160 disease-associated mutant allele, establishing loss-of-function phenotypes for two compound-heterozygous mutations identified in a patient with steroid-resistant nephrotic syndrome. |
Drosophila nephrocyte-specific RNAi knockdown; rescue by wild-type and mutant human NUP160 expression; functional assays for nephrocyte function, cell size, nuclear volume, nuclear membrane structure |
Journal of the American Society of Nephrology : JASN |
Medium |
30910934
|
| 2024 |
Podocyte-specific knockout of Nup160 in mice causes progressive proteinuria, reduced serum albumin, and glomerulosclerosis, directly demonstrating that loss of Nup160 in podocytes is sufficient to produce nephrotic syndrome phenotypes. |
Podocyte-specific Nup160 knockout mice generated by CRISPR/Cas9 and Cre/loxP; protein and DNA level verification; urinary albumin/creatinine ratio, serum albumin, histology |
Human molecular genetics |
High |
38224683
|
| 2025 |
Loss of Nup160 in podocytes of podocyte-specific knockout mice decreases Cdc42 protein levels and reduces Cdc42 activity (despite elevated Cdc42 mRNA), linking NUP160 to post-transcriptional regulation of Cdc42 and suggesting that CDC42 dysregulation contributes to NUP160-associated steroid-resistant nephrotic syndrome pathogenesis. |
Podocyte-specific Nup160 KO mouse with double-fluorescent Cre reporter; single-cell transcriptomics and proteomics of glomerular cells; primary podocyte culture; Cdc42 activity assay; Western blot; RT-qPCR |
Human molecular genetics |
Medium |
40298220
|
| 2021 |
Knockdown of NUP160 in high glucose-treated kidney tubular cells and STZ-induced diabetic nephropathy mice restores autophagic flux (increased LC3II/LC3I ratio, decreased p62) and reduces NF-κB-dependent inflammation and fibrosis, identifying NUP160 as a regulator of autophagy in diabetic nephropathy. |
shRNA knockdown in NRK-52E cells; STZ mouse model; Western blot for autophagy markers, NF-κB pathway components, and inflammatory cytokines; histological staining in vivo |
Bioengineered |
Medium |
34533106
|
| 2023 |
NUP160 knockdown in high glucose-treated podocytes activates the JAK2/STAT3 signaling pathway (increased p-JAK2/JAK2 and p-STAT3/STAT3 ratios) and reduces autophagic flux (decreased LC3B-II/LC3B-I), indicating that NUP160 regulates cellular autophagy through the JAK2/STAT3 pathway. |
siRNA knockdown in podocytes; Western blot for JAK2/STAT3 phosphorylation and LC3B; flow cytometry for apoptosis |
Iranian journal of kidney diseases |
Low |
38043110
|
| 2019 |
microRNA-577 directly targets NUP160 mRNA (validated by dual-luciferase reporter assay), and upregulation of miR-577 reduces NUP160 expression in CML cells, linking NUP160 to imatinib sensitivity in chronic myeloid leukemia. |
Dual-luciferase reporter assay; qRT-PCR; cell proliferation and cycle assays; cell reverse test for drug sensitivity |
European review for medical and pharmacological sciences |
Low |
31486501
|
| 2025 |
circRAPGEF5 interacts with the KH3-4 domain of IGF2BP2, which then stabilizes NUP160 mRNA; elevated NUP160 suppresses autophagic flux in lung adenocarcinoma cells, and RNAi-mediated knockdown of NUP160 restores autophagy and attenuates malignant behaviors in vitro and in vivo. |
RNA pulldown, mass spectrometry, RNA immunoprecipitation; m6A-RIP-PCR; immunofluorescence; FISH; mRFP-GFP-LC3 lentiviral labeling for autophagy flux; xenograft mouse model; siRNA knockdown |
Molecular cancer |
Medium |
40629330
|